Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy

Neuroscience

Volumn 220, Issue , 2012, Pages 247-255

  Rangroo Thrane, V ^a,b   Thrane, A S ^a,b   Chanag, J ^a   Alleluia, V ^a   Nagelhus, E A ^b   Nedergaard, M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Ammonia; Azoxymethane; Blood brain barrier; Microglia; Two photon

Indexed keywords

AMMONIA; AZOXYMETHANE; CHEMOKINE RECEPTOR CX3CR1; ENHANCED GREEN FLUORESCENT PROTEIN;

AMMONIA BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN EDEMA; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELL MOTILITY; CELL STRUCTURE; COMA; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; HYPERAMMONEMIC ENCEPHALOPATHY; IN VIVO STUDY; MALE; MICROGLIA; MOLECULAR IMAGING; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CELL MOVEMENT; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MICROSCOPY, CONFOCAL;

EID: 84864778906     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.06.022     Document Type: Article

References (38)

1. Agusti A., Cauli O., Rodrigo R., Llansola M., Hernandez-Rabaza V., Felipo V. P38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Gut 2011, 60:1572-1579.
2. Belanger M., Cote J., Butterworth R.F. Neurobiological characterization of an azoxymethane mouse model of acute liver failure. Neurochem Int 2006, 48:434-440.
3. Bemeur C., Desjardins P., Butterworth R.F. Antioxidant and anti-inflammatory effects of mild hypothermia in the attenuation of liver injury due to azoxymethane toxicity in the mouse. Metab Brain Dis 2010, 25:23-29.
4. Bemeur C., Vaquero J., Desjardins P., Butterworth R.F. N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice. antioxidant and anti-inflammatory mechanisms. Metab Brain Dis 2010, 25:241-249.
5. Biber K., Tsuda M., Tozaki-Saitoh H., Tsukamoto K., Toyomitsu E., Masuda T., Boddeke H., Inoue K. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J 2011, 30:1864-1873.
6. Bruck J., Gorg B., Bidmon H.J., Zemtsova I., Qvartskhava N., Keitel V., Kircheis G., Haussinger D. Locomotor impairment and cerebrocortical oxidative stress in portal vein ligated rats in vivo. J Hepatol 2011, 54:251-257.
7. Butterworth R.F. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002, 17:221-227.
8. Butterworth R.F. Hepatic encephalopathy: a central neuroinflammatory disorder?. Hepatology (Baltimore, MD) 2011, 53:1372-1376.
9. Butterworth R.F., Norenberg M.D., Felipo V., Ferenci P., Albrecht J., Blei A.T. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 2009, 29:783-788.
10. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021.
11. Dombeck D.A., Khabbaz A.N., Collman F., Adelman T.L., Tank D.W. Imaging largescale neural activity with cellular resolution in awake, mobile mice. Neuron 2007, 56:43-57.
12. Fuhrmann M., Bittner T., Jung C.K., Burgold S., Page R.M., Mitteregger G., Haass C., LaFerla F.M., Kretzschmar H., Herms J. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci 2010, 13:411-413.
13. Greenberg D.S., Houweling A.R., Kerr J.N. Population imaging of ongoing neuronal activity in the visual cortex of awake rats. Nat Neurosci 2008, 11:749-751.
14. Haj-Yasein N.N., Vindedal G.F., Eilert-Olsen M., Gundersen G.A., Skare O., Laake P., Klungland A., Thoren A.E., Burkhardt J.M., Ottersen O.P., Nagelhus E.A. Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet. Proc Nat Acad Sci U S A 2011, 108:17815-17820.
15. Hayashi Y., Kawaji K., Sun L., Zhang X., Koyano K., Yokoyama T., Kohsaka S., Inoue K., Nakanishi H. Microglial Ca(2+)-activated K(+) channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain. J Neurosci 2011, 31:17370-17382.
16. Jack C., Ruffini F., Bar-Or A., Antel J.P. Microglia and multiple sclerosis. J Neurosci Res 2005, 81:363-373.
17. Jiang W., Desjardins P., Butterworth R.F. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. J Neurochem 2009, 109:485-493.
18. Jiang W., Desjardins P., Butterworth R.F. Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats. Neurochem Int 2009, 55:601-605.
19. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol Rev 2011, 91:461-553.
20. Lee S., Varvel N.H., Konerth M.E., Xu G., Cardona A.E., Ransohoff R.M., Lamb B.T. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am J Pathol 2010, 177:2549-2562.
21. Liu B. Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J 2006, 8:E606-621.
22. Lynch N.J., Willis C.L., Nolan C.C., Roscher S., Fowler M.J., Weihe E., Ray D.E., Schwaeble W.J. Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats. Mol Immunol 2004, 40:709-716.
23. Marchetti P., D'Avanzo C., Orsato R., Montagnese S., Schiff S., Kaplan P.W., Piccione F., Merkel C., Gatta A., Sparacino G., Toffolo G.M., Amodio P. Electroencephalography in patients with cirrhosis. Gastroenterology 2011, 141(1680-1689):e1681-e1682.
24. Martinez-Hernandez A., Bell K.P., Norenberg M.D. Glutamine synthetaseglial localization in brain. Science (New York, NY) 1977, 195:1356-1358.
25. Matkowskyj K.A., Marrero J.A., Carroll R.E., Danilkovich A.V., Green R.M., Benya R.V. Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice. characterization of a new animal model. Am J Physiol 1999, 277:G455-G462.
26. Mount M.P., Lira A., Grimes D., Smith P.D., Faucher S., Slack R., Anisman H., Hayley S., Park D.S. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 2007, 27:3328-3337.
27. Nguyen J.H., Yamamoto S., Steers J., Sevlever D., Lin W., Shimojima N., Castanedes-Casey M., Genco P., Golde T., Richelson E., Dickson D., McKinney M., Eckman C.B. Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. J Hepatol 2006, 44:1105-1114.
28. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (New York, NY) 2005, 308:1314-1318.
29. Pascual O., Ben Achour S., Rostaing P., Triller A., Bessis A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Nat Acad Sci U S A 2012, 109:E197-E205.
30. Prinz M., Priller J., Sisodia S.S., Ransohoff R.M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 2011, 14:1227-1235.
31. Ransohoff R.M., Cardona A.E. The myeloid cells of the central nervous system parenchyma. Nature 2010, 468:253-262.
32. Ratnakumari L., Qureshi I.A., Butterworth R.F. Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency. Metab Brain Dis 1994, 9:43-51.
33. Rodrigo R., Cauli O., Gomez-Pinedo U., Agusti A., Hernandez-Rabaza V., Garcia-Verdugo J.M., Felipo V. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 2010, 139:675-684.
34. Schwartz M., Butovsky O., Bruck W., Hanisch U.K. Microglial phenotype: is the commitment reversible?. Trends Neurosci 2006, 29:68-74.
35. Takata N., Hirase H. Cortical layer 1 and layer 2/3 astrocytes exhibit distinct calcium dynamics in vivo. PLoS One 2008, 3:e2525.
36. Vinet J., Weering H.R., Heinrich A., Kalin R.E., Wegner A., Brouwer N., Heppner F.L., Rooijen N., Boddeke H.W., Biber K. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J Neuroinflamm 2012, 9:27.
37. Wu J., Yang S., Hua Y., Liu W., Keep R.F., Xi G. Minocycline attenuates brain edema, brain atrophy and neurological deficits after intracerebral hemorrhage. Acta Neurochi Suppl 2010, 106:147-150.
38. Zemtsova I., Gorg B., Keitel V., Bidmon H.J., Schror K., Haussinger D. Microglia activation in hepatic encephalopathy in rats and humans. Hepatology (Baltimore, MD) 2011, 54:204-215.